Navigation Links
PennWell's Strategies in Biophotonics Event Adds Two New Advisory Board Members
Date:9/16/2013

TULSA, Okla., Sept. 16, 2013 /PRNewswire/ -- Strategies in Biophotonics Conference & Expo, a newly developed PennWell event scheduled for September 9-11, 2014, in Boston, MA at the Boston Park Plaza Hotel, has added to its advisory board Dr. Juergen Popp and Dale Wahlstrom.

(Logo: http://photos.prnewswire.com/prnh/20130814/DA64213LOGO-a)

(Logo: http://photos.prnewswire.com/prnh/20130814/DA64213LOGO-b)   

(Logo: http://photos.prnewswire.com/prnh/20110627/DA26630LOGO)

Dr. Popp, Strategies in Biophotonics Conference & Expo's first international representative, is chair for Physical Chemistry at the Friedrich-Schiller University Jena (Germany) and Scientific Director of the Institute of Photonic Technology, Jena. A theme in Dr. Popp's work is bringing together scientists, commercial system developers, and clinicians to help ensure that biophotonics technology is addressing real needs and can be fully realized as tools for clinicians and researchers.

Dale Wahlstrom is the president and CEO of LifeScience Alley (LSA) and the BioBusiness Alliance of Minnesota (BBAM). He also is a member of the board of directors of the Medical Device Innovation Consortium, a public-private partnership between the FDA and the medical device industry.

Strategies in Biophotonics Conference & Expo will address critical but often-overlooked issues that technology innovators must address in order to succeed in efforts to commercialize biophotonics-based systems. The program will include key examples to highlight clinical and scientific needs, demonstrate how biomedical optics and photonics can address them, and discuss requirements for the technologies to reach that goal.

As conference co-chairs, Barbara Goode, Editor-in-Chief of BioOptics World, and Conard Holton, Editor-in-Chief of Laser Focus World, are assembling an industry-leading advisory board to develop conference content. So far the board includes:

  • Robert R. Alfano, PhD, Distinguished Professor of Science and Engineering and Director of Institute for Ultrafast Spectroscopy and Lasers, City College of the City University of New York
  • Thomas M. Baer, PhD, Executive Director, Stanford Photonics Research Center; Co-Founder, Arcturus Bioscience, Inc.
  • Robert Chimenti, Sr. Strategic Applications Engineer, Innovative Photonic Solutions
  • John Dexheimer, President, LightWave Advisors, Inc.
  • Thomas J. Dudley, Assistant Director, Photonics Center, Boston University
  • Ken Kaufmann, PhD, VP of Marketing, Hamamatsu Corp.
  • Robert J. Nordstrom, PhD, Program Director, Cancer Imaging Program, National Institutes of Health National Cancer Initiative
  • Aydogan Ozcan, PhD, Associate Professor, head of Bio- and Nano-Photonics Laboratory, UCLA; Founder, Holomic LLC
  • Rick Plympton, CEO, Optimax Systems Inc.
  • Juergen Popp, PhD, Scientific Director of the Institute of Photonic Technology and chair for Physical Chemistry at the Friedrich-Schiller University Jena
  • Dale Wahlstrom, president and CEO of LifeScience Alley (LSA) and BioBusiness Alliance of Minnesota

Among the roughly 40 exhibitors expected are: Applied Image Inc, B&W Tek, Laser Components, OFS Optics and Princeton Instruments.

For more information and to register for Strategies in Biophotonics Conference & Expo, visit http://www.strategiesinbiophotonics.com.

About PennWell

PennWell Corp. is a diversified business-to-business media and information company that provides quality content and integrated marketing solutions for the following industries: electric power, water and wastewater, oil and gas, renewable energy, electronics, semiconductor, contamination control, photonics, fiberoptics, enterprise storage, nanotechnology, fire, emergency services and dental. Founded in 1910, PennWell publishes over 100 print and online magazines and newsletters, conducts 60 conferences and exhibitions on six continents, and has an extensive offering of books, maps, web sites, research and database services. In addition to PennWell's headquarters in Tulsa, Oklahoma the Company has major offices in Nashua, New Hampshire; Houston, Texas; London, England; Mountain View, California; Fairlawn, New Jersey; Moscow, Russia; and Hong Kong, China. In 2010, PennWell celebrated 100 years in business.

Contact: Danette Ward
Sr. Marketing Manager, PennWell
P: 918.832.9379
danettew@pennwell.com


'/>"/>
SOURCE PennWell Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Enhanced Strategies for Design and Execution of Biomarker-driven Oncology Trials, new life science webinar hosted by Xtalks
2. Optimizing Assays from FFPE for Biomarker Strategies, New Life Science Webinar Hosted by Xtalks
3. Strategies for Rare Disease Studies and Orphan Drug Development in Europe; New Life Science Webinar Hosted by Xtalks
4. Infinata's BioPharm Insight Global Editor Kim Ha to Moderate Panel at 3rd Annual U.S.-China Conference on Strategies for Mining Profits from Pharma Opportunities in China
5. Point-of-Delivery Drug. Reconstitution Systems Markets, Strategies and Prospects
6. Effective Strategies for Managing Comparator Product Testing, New Webinar Hosted by Xtalks
7. ASAE Releases Book Providing Associations with Strategies for New Normal
8. New Product Launch: Are your Strategies for Emerging Healthcare and Life Sciences Markets Innovative and Structured?
9. Item Level Serialization and Anti-counterfeiting Drug Strategies
10. ResearchMoz: DSL Chips Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2018 - Market Research Report
11. Webinar on Clinical, Regulatory and Commercialization Strategies for Rare Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. spent ... entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, 2017 ... joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, Grossmont ...
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
(Date:8/23/2017)... public,s help is being enlisted in what,s thought to be the biggest ... human body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest study to date ... project's goal is to help advance scientific knowledge of the role of ... The ...
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) ... international tech event dedicated to developing collaboration between startups and ... on June 15-17. During the event, nine startups will showcase ... value in various industries. France ... the international market, with a 30 percent increase in the ...
(Date:4/24/2017)... , April 24, 2017 Janice ... partner with  Identity Strategy Partners, LLP (IdSP) , ... or without President Trump,s March 6, 2017 ... Entry , refugee vetting can be instilled with greater ... (Right now, all refugee applications are suspended by ...
Breaking Biology News(10 mins):